logo
Booster Dose For Hirings At Arogya Centres In City

Booster Dose For Hirings At Arogya Centres In City

Time of India5 days ago
New Delhi: In a bid to fast-track staffing at Ayushman Arogya Mandirs (AAMs), Delhi govt has proposed a one-time age relaxation of up to 10 years for the recruitment of key healthcare personnel, including doctors.
The appointments will be contractual and made under National Health Mission (NHM) norms, with fixed monthly salaries.
Unlike mohalla clinics, where staff are paid based on the number of patients seen, AAM employees will receive structured remuneration. The proposal, which aims to expedite hiring amid a ticking funding deadline, has been sent to lieutenant governor VK Saxena for final approval.
Officials said the move was likely to benefit many, especially existing mohalla clinic workers, by allowing them to apply for AAM positions if they meet the eligibility criteria.
"Anyone who is qualified, whether currently working in a mohalla clinic or elsewhere, can apply. Appointments will be merit-based," said a senior health department official.
You Can Also Check:
Delhi AQI
|
Weather in Delhi
|
Bank Holidays in Delhi
|
Public Holidays in Delhi
Under the Indian Public Health Standards, each AAM sub-centre is expected to have one medical officer, one pharmacist, and one multipurpose health worker (MHW). A staff nurse may be deployed in the MHW role if their qualification is ANM or higher.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
You Won't Believe the Price of These Dubai Apartments
Binghatti Developers FZE
Get Offer
Undo
Sanitation and security services can be hired or outsourced.
Currently, the maximum age limits for these positions are 45 years for medical officers and 30 years for pharmacists and MHWs. The proposed relaxation will allow candidates up to 55 years of age to be considered, significantly expanding the pool of eligible applicants.
The urgency stems from the timeline of the centrally funded PM-Ayushman Bharat Health Infrastructure Mission, under which AAMs sub-centres are being set up.
The scheme, launched in 2021–22, focuses on preventive and wellness care and is funded until March 2026. After that, the financial responsibility is expected to shift to state govts unless extended by the Centre.
Given the time required for recruitment and infrastructure rollout, officials say the relaxation is a necessary step to ensure AAMs are functional before the funding cycle ends.
"This one-time provision is designed to speed up recruitment without compromising on quality," the official added.
The initiative comes amid rising demand for decentralised, preventive healthcare across Delhi. If approved, the age relaxation could pave the way for thousands of experienced healthcare workers to transition into the new model of care delivery.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

So it was not diabetes but the common diabetes pill which was causing heart disease! Shocking research reveals the unbelievable!
So it was not diabetes but the common diabetes pill which was causing heart disease! Shocking research reveals the unbelievable!

Time of India

time36 minutes ago

  • Time of India

So it was not diabetes but the common diabetes pill which was causing heart disease! Shocking research reveals the unbelievable!

For many living with type 2 diabetes, managing blood sugar is a daily reality. Often, medications come as a lifeline, and among them, sulfonylureas like glipizide are popular choices, especially in the US. They've been around for decades, are affordable, and have shown effective results in keeping glucose in check. But now, a new study has cast a shadow over this commonly used medicine. Researchers have discovered a possible link between glipizide and increased heart-related risks. Here's what the study found, what it truly means, and why this matters to families where diabetes is part of everyday conversations. Glipizide: Familiar, trusted, But now under scrutiny Glipizide belongs to a group of drugs called sulfonylureas. For decades, these medications have been trusted for lowering blood sugar in people with type 2 diabetes, often when metformin alone isn't enough. What made glipizide popular was its affordability and long-standing availability. But popularity doesn't always mean perfection. The latest study signals a possible red flag. Involving nearly 48,000 individuals, this research found that those taking glipizide had a higher risk of heart attacks, strokes, heart failure hospitalisations, and even cardiovascular-related deaths than those taking a newer class of drugs called DPP-4 inhibitors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe the Price of These Dubai Apartments Binghatti Developers FZE Get Offer Undo The numbers that raised eyebrows The research compared glipizide with other sulfonylureas like glimepiride and glyburide, along with DPP-4 inhibitors. Here's what stood out: Over a 5-year period, the risk of major heart events was 9.1% in those taking glipizide, while for those on DPP-4 inhibitors, it was 8.1%. The risk ratio for glipizide users was 1.13, indicating a 13% higher risk of cardiovascular events compared to DPP-4 inhibitor users. The risk was also slightly higher with glimepiride (8.6%) and glyburide (8.4%), but not statistically significant. What makes this important is that most participants were on their second diabetes medication after metformin, a common scenario in diabetes care. And they weren't at extremely high cardiac risk to begin with, just moderate, everyday individuals managing a chronic condition. Not just about the numbers, but about what they mean It's easy to be alarmed by statistics. But what do these numbers truly tell us? Firstly, the study doesn't claim that glipizide causes heart problems directly. What it suggests is a possible association, a pattern that raises concerns, especially in people already facing moderate cardiovascular risk. The heart, after all, is already under pressure in type 2 diabetes. When a drug meant to help with sugar control potentially adds to that risk, even slightly, it becomes a serious discussion for healthcare providers. Why affordability might come at a cost Sulfonylureas like glipizide are often the go-to option in low- and middle-income settings because they're inexpensive. DPP-4 inhibitors, on the other hand, are costlier but have a more favourable cardiovascular safety profile. This raises a deeper, more sensitive question: should treatment decisions depend on cost or safety? The answer isn't straightforward. But studies like this push for better informed decisions, where doctors weigh more than just sugar levels, they also look at heart health, overall risk, and long-term quality of life. What this means for families dealing with diabetes This isn't about pushing panic buttons. Glipizide is still an approved and effective drug. But the study offers important insights for personalised diabetes management. It's a reminder that medications work differently for different people, and what works well for one might not be ideal for another, especially when silent risks like cardiovascular strain are involved. It's also a cue to revisit older medications with a fresh lens, especially when newer, safer options are available. The story here isn't about fear, but about awareness and agency. (Inputs from agencies)

What Is dry eye disease? Symptoms, causes & how to treat it
What Is dry eye disease? Symptoms, causes & how to treat it

Time of India

timean hour ago

  • Time of India

What Is dry eye disease? Symptoms, causes & how to treat it

Feeling constant eye irritation, burning, or blurred vision after long hours on your phone or laptop? You might be experiencing dry eye disease, a fast-growing modern condition linked to excessive screen time, pollution, and even air conditioning. Once considered a minor inconvenience, it's now recognised as a chronic issue that can affect daily productivity and long-term eye health. Urban lifestyles, digital overload, and poor blinking habits are all culprits. But the good news? Science-backed solutions exist. In this article, we break down what dry eye disease really is, why it's becoming so common, and how to treat and prevent it effectively. What is dry eye disease? Dry eye disease occurs when your eyes either don't produce enough tears or the tears evaporate too quickly. This leads to symptoms like dryness, irritation, a gritty sensation, or even blurred vision. But it's more than just lack of moisture. According to the TFOS DEWS II Report (2017) , dry eye is a complex medical condition involving an unstable tear film, ocular surface inflammation, and in some cases, nerve dysfunction. These factors disrupt normal tear production and eye lubrication, making the condition chronic and often progressive if left untreated. Why is dry eye disease becoming so common? In today's digital-first, urban lifestyle, dry eye disease is rapidly becoming one of the most widespread eye conditions worldwide. But why are more people, especially young adults and even children, experiencing dry, irritated eyes? Here are the top scientifically proven reasons: Too much screen time Staring at phones, laptops, and TVs for long periods significantly reduces your blink rate, causing your tears to evaporate more quickly. This leads to unstable tear film and increased eye dryness. A study by Moon et al . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Prettiest Icons In The History The Noodle Box Undo (2023) revealed that even school children who use digital devices frequently are showing early signs of dry eye disease, pointing to how screen overuse is affecting eye health from a young age. Pollution in the air Airborne pollutants especially PM₂.₅, ozone (O₃), and sulfur dioxide (SO₂) can damage the ocular surface, destabilise your tear film, and trigger chronic inflammation. A large multicenter study by Ran Hao et al. (Frontiers in Medicine, 2022) demonstrated that exposure to these air pollutants was strongly associated with meibomian gland dysfunction, elevated tear cytokine levels, and worsening dry eye symptoms in urban patients. Meibomian gland dysfunction (MGD) Your eyelids contain meibomian glands that secrete oils essential for preventing your tears from evaporating too fast. When these glands become clogged or inflamed, they can no longer protect the tear film effectively, causing evaporative dry eye the most common subtype of dry eye disease today. Other factors Aging and hormonal changes (especially in women) Medical conditions like diabetes and autoimmune diseases Medications like antidepressants, antihistamines, acne pills What are the symptoms of dry eye disease? Not sure if you have it? Watch out for these common symptoms: Burning or stinging in the eyes Redness or irritation Blurry or fluctuating vision Eyes that water too much (sounds odd but it's a response to dryness!) Eye fatigue, especially after using screens These symptoms can affect your focus, work, and even mood over time. How to treat dry eye disease The good news? You can manage dry eye disease with a mix of home care and medical treatments. Here's what works: Artificial tears Over-the-counter artificial tears are often the first line of treatment for dry eye disease. They help replenish moisture on the surface of the eye and relieve symptoms like burning, stinging, and grittiness. For long-term use, it's best to choose preservative-free variants, as preservatives in some eye drops can cause irritation when used too often. These drops can be used several times a day and are especially helpful after prolonged screen time, exposure to wind, or air-conditioned environments. Warm compresses Applying a warm compress over closed eyelids helps to melt the thickened oil in the Meibomian glands, which are responsible for producing the oily layer of your tear film. When these glands get clogged, it leads to quicker evaporation of tears. Use a clean, warm towel or a microwavable eye mask for 5–10 minutes daily. This not only promotes better oil flow but also soothes inflammation and improves overall comfort, especially for those with Meibomian Gland Dysfunction (MGD). Lid hygiene Proper eyelid hygiene is crucial for managing dry eye, especially if you have blepharitis or oil gland issues. Cleaning your eyelids daily helps remove debris, dead skin, and bacteria that can cause inflammation. Use a doctor-recommended lid scrub, diluted baby shampoo, or pre-moistened sterile wipes. Gently clean the base of your eyelashes with a cotton pad or swab. Consistent lid hygiene reduces flare-ups, stabilises the tear film, and improves overall eye comfort. Omega-3 fatty acids Multiple studies have shown that omega-3 supplements, especially those containing EPA and DHA can significantly improve dry eye symptoms by enhancing the quality of oil in your tears. These healthy fats reduce inflammation and support Meibomian gland function. Sources include fish oil capsules, flaxseed oil, chia seeds, and walnuts. Talk to your doctor about dosage, as high-quality supplements may be more effective. They're not a quick fix, but over time, they can be a game-changer for dry eye relief. Prescription eye drops For moderate to severe dry eye cases, your doctor may prescribe medicated eye drops like cyclosporine (Restasis) or lifitegrast (Xiidra). These work by targeting the inflammation in the tear glands and improving natural tear production. Unlike artificial tears, these drops take a few weeks to show results but address the root cause of chronic dry eye. They're especially effective in autoimmune-related cases or when standard over-the-counter drops are not enough. Environmental changes Use a humidifier Avoid dry air or direct AC Follow the 20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds Dry eye disease is more than just an uncomfortable feeling, it's a real medical condition made worse by modern habits and pollution. The good news? With science-backed treatments and small lifestyle changes, you can get long-term relief and protect your eye health. Don't ignore the signs your eyes are trying to tell you something! Also read| 7,000 steps a day can reduce the risk of diseases like cancer, dementia, and heart problems

Low insurance costs, affordable treatment and medicines drawing NRIs to India
Low insurance costs, affordable treatment and medicines drawing NRIs to India

Time of India

time2 hours ago

  • Time of India

Low insurance costs, affordable treatment and medicines drawing NRIs to India

While treatment costs in India are low, so are the medical insurance premiums. (AI image) New Delhi: Low medical insurance premiums, affordable treatment costs and high quality healthcare facilities at private hospitals are making NRIs turn to India for medical treatment, according to a report by Policybazaar. The insurance aggregator noted that the share of NRI buyers of health insurance grew 150% in 2024-25 as compared to the previous year. One of India's most compelling advantages is the dramatic cost difference for medical procedures. Healthcare costs in India are very low compared to what one pays in the US and other developed countries. Patients can save 60-90% on treatments in India. To give you a perspective, here's a comparison of the costs of some surgical procedures in the two countries. Figures are indicative and actual costs may vary depending on the hospital chosen and the location. Treatment Cost in the US Cost in India Heart bypass surgery Rs 60 lakh to Rs 1.3 crore Rs 4.5 lakh to Rs 8 lakh Knee replacement Rs 25 lakh to Rs 45 lakh Rs 3.5 lakh to Rs 5 lakh Liver transplant Rs 2.5 crore to Rs 4 crore Rs 21 lakh to Rs 30 lakh Kidney transplant Rs 1.7 crore to Rs 2.6 crore Rs 6 lakh to Rs 10 lakh *US figures converted to rupees at Rs 86.5 per dollar. Source: Policybazaar While treatment costs in India are low, so are the medical insurance premiums compared to what one pays in the US and other countries. The average annual health insurance premium per person in India is $120-300 (Rs 10,000-26,000), which is significantly lower than $8,000 (Rs 6.9 lakh) payable in the US or $4,000-5,000 (Rs 3.4-4.3 lakh) charged in GCC countries. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Walmart Cameras Captured These Hilarious 20 Photos Undo This has led many NRIS to purchase health cover from insurance companies in India. Policybazaar has also noted a surge in online queries from NRIs expressing interest to buy health insurance in India. According to Google Trends and industry search data, queries like 'Best health insurance plans for parents in India' consistently ranks among the top 5 NRI-related insurance searches from the UAE, UK, and US markets. What's more, even medicines in India are significantly cheaper. For example, a vial of insulin costs Rs 85-400 in India versus Rs 8,600-25,000 in the US. The cost of medicines can add up to a huge amount, but insurance helps cover these at low costs. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store